Domača stranLLY • SWX
add
Eli Lilly and Company
Prejšnji trg. dan.
830,00 CHF
Letni razpon
386,00 CHF - 830,00 CHF
Tržna kapitalizacija
894,90 mrd. USD
Povprečni obseg
11,00
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | mar. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 8,77 mrd. | 25,98 % |
Stroški poslovanja | 4,36 mrd. | 20,46 % |
Čisti dohodek | 2,24 mrd. | 66,77 % |
Čista dobičkovnost prihodkov | 25,58 | 32,40 % |
Earnings per share | 2,58 | 59,26 % |
EBITDA | 3,14 mrd. | 50,99 % |
Efektivna davčna stopnja | 11,56 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | mar. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 2,65 mrd. | −28,79 % |
Skupna sredstva | 63,94 mrd. | 20,28 % |
Skupne obveznosti | 51,05 mrd. | 21,92 % |
Celoten lastniški kapital | 12,90 mrd. | — |
Shares outstanding | 900,41 mio. | — |
Razmerje P/B | 58,33 | — |
Donosnost sredstev | 10,69 % | — |
Donosnost kapitala | 17,86 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | mar. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 2,24 mrd. | 66,77 % |
Denar iz dejavnosti | 1,17 mrd. | −32,62 % |
Denar iz naložb | −1,18 mrd. | −70,96 % |
Denar iz financiranja | −311,30 mio. | −175,50 % |
Neto sprememba denarnih sredstev | −358,40 mio. | −124,23 % |
Prost denarni tok | −2,01 mrd. | −273,63 % |
Vizitka
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.
As of 2024, the company is ranked 127th on the Fortune 500 with revenue of $34.12 billion. It is ranked 221st on the Forbes Global 2000 list of the world's largest publicly-traded companies and 252nd on the Forbes list of "America's Best Employers". It is recognized as the top entry-level employer in Indianapolis.
Lilly is known for its clinical depression drugs Prozac, Cymbalta, and its antipsychotic medication Zyprexa. The company's primary revenue drivers are the diabetes drugs Humalog and Trulicity.
Lilly was the first company to mass-produce both the polio vaccine, developed in 1955 by Jonas Salk, and insulin. It was one of the first pharmaceutical companies to produce human insulin using recombinant DNA, including Humulin, Humalog, and the first approved biosimilar insulin product in the U.S., Basaglar. Wikipedia
Generalni direktor
Datum ustanovitve
1876
Sedež organizacije
Spletno mesto
Zaposleni
43.000
